| __timestamp | Sarepta Therapeutics, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 49315000 | 7461000 |
| Thursday, January 1, 2015 | 75043000 | 11960000 |
| Friday, January 1, 2016 | 83749000 | 13108000 |
| Sunday, January 1, 2017 | 122682000 | 17501000 |
| Monday, January 1, 2018 | 207761000 | 22472000 |
| Tuesday, January 1, 2019 | 284812000 | 24286000 |
| Wednesday, January 1, 2020 | 317875000 | 29689000 |
| Friday, January 1, 2021 | 282660000 | 38837000 |
| Saturday, January 1, 2022 | 451421000 | 47489000 |
| Sunday, January 1, 2023 | 481871000 | 53379000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Sarepta Therapeutics, Inc. and Xencor, Inc. have shown contrasting strategies in this area. From 2014 to 2023, Sarepta's SG&A expenses surged by over 870%, reflecting its aggressive growth and expansion strategy. In contrast, Xencor maintained a more conservative approach, with a 615% increase, indicating a focus on cost efficiency.
Sarepta's expenses peaked in 2023, reaching nearly 10 times their 2014 levels, while Xencor's expenses grew to about 7 times their initial value. This divergence highlights the different paths these companies have taken in scaling their operations. As investors and industry watchers analyze these trends, the question remains: which strategy will yield better long-term returns?
Who Optimizes SG&A Costs Better? Zoetis Inc. or Sarepta Therapeutics, Inc.
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc. Trends and Insights
United Therapeutics Corporation vs Xencor, Inc.: SG&A Expense Trends
Intra-Cellular Therapies, Inc. vs Xencor, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Dr. Reddy's Laboratories Limited or Xencor, Inc.: Who Manages SG&A Costs Better?
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Sarepta Therapeutics, Inc. or MorphoSys AG: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Sarepta Therapeutics, Inc. or Evotec SE
Jazz Pharmaceuticals plc vs Xencor, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Madrigal Pharmaceuticals, Inc. and Xencor, Inc.
Operational Costs Compared: SG&A Analysis of Bausch Health Companies Inc. and Xencor, Inc.